Hifas da Terra develops a new product with positive impact on memory and cognitive impairment

New product for memory and cognitive impairment

Hifas da Terra (HdT) and Cuevas y Cía announced the results of the trial carried out at the Foltra Health Centre (Foltra Foundation), which shows that the daily intake of a new functional food has a significant impact on critical aspects of neurological health such as memory and attention, and may also be useful in cognitive impairment associated with conditions such as Alzheimer’s disease.

Hifas da Terra and Anfaco-Cecopesca propose innovative solutions for health from the smart industry in the Nutrigen 4.0 project

Nutrigen 4.0 Project Tour

The overall objective of the R&D&I project ‘NutriGen 4.0’ is to design a biotechnological process, which can monitor, simulate and predict outcomes so nutraceuticals can be created by means of advanced calculation and modelling tools.

Study in nursing home residents demonstrates a reduction in both mortality from and associated complications of COVID-19

Hifas da Terra’s released the preliminary results of the trial of mycotherapeutic supplements in nursing home residents diagnosed with COVID-19, which demonstrated that supplementation with immunomodulatory nutraceuticals can significantly improve the situation of those most vulnerable to the pandemic by reducing both mortality and complications associated with infection by SARS-COV-2.

Research proves that mushrooms could prevent cognitive impairment 

The key to the prevention of cognitive impairment could be in the unique antioxidant and anti-inflammatory substances that mushrooms contain. The conclusions of this research indicate a regular consumption could prevent by 50% the problems associated with mild cognitive impairment (MCI) such as memory loss, speech or attention difficulties, etc.